LITHOBID is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Lithium Carbonate.
Product ID | 62559-280_37f8949f-f3f0-4f1a-8a21-4f940fbadf6d |
NDC | 62559-280 |
Product Type | Human Prescription Drug |
Proprietary Name | LITHOBID |
Generic Name | Lithium Carbonate |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2014-07-01 |
Marketing Category | NDA / NDA |
Application Number | NDA018027 |
Labeler Name | ANI Pharmaceuticals, Inc. |
Substance Name | LITHIUM CARBONATE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Mood Stabilizer [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018027 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-07-01 |
Ingredient | Strength |
---|---|
LITHIUM CARBONATE | 300 mg/1 |
SPL SET ID: | f7f5b69a-c2a1-4586-a189-1475d41387c0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
62559-280 | LITHOBID | LITHOBID |
0054-0020 | Lithium Carbonate | Lithium Carbonate |
0054-0021 | Lithium Carbonate | Lithium Carbonate |
0054-2526 | Lithium Carbonate | Lithium Carbonate |
0054-2527 | Lithium Carbonate | Lithium Carbonate |
0054-2531 | Lithium Carbonate | Lithium Carbonate |
0054-4527 | Lithium Carbonate | Lithium Carbonate |
0054-8526 | Lithium Carbonate | Lithium Carbonate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LITHOBID 73219510 1147470 Live/Registered |
Rowell Laboratories, Inc. 1979-06-13 |